Author
Listed:
- Kazuyoshi Takeda
(Biomedical Research Center, Graduate School of Medicine, Juntendo University
Graduate School of Medicine, Juntendo University
Juntendo University School of Medicine
Cancer Immunology Program, Peter MacCallum Cancer Centre, St Andrews Place)
- Masafumi Nakayama
(Frontier Research Institute for Interdisciplinary Sciences, Tohoku University
Institute of Development, Aging, and Cancer, Tohoku University)
- Yoshihiro Hayakawa
(Cancer Immunology Program, Peter MacCallum Cancer Centre, St Andrews Place
Institute of Natural Medicine, University of Toyama, Sugitani 2630)
- Yuko Kojima
(Laboratory of Morphology and Image Analysis, Biomedical Research Center, Juntendo University Graduate School of Medicine)
- Hiroaki Ikeda
(Mie University Graduate School of Medicine, 2-174 Edobashi
Nagasaki University Graduate School of Biomedical Science, 1-12-4 Sakamoto)
- Naoko Imai
(Mie University Graduate School of Medicine, 2-174 Edobashi
Icahn School of Medicine at Mount Sinai, 1470 Madison Avenue)
- Kouetsu Ogasawara
(Institute of Development, Aging, and Cancer, Tohoku University)
- Ko Okumura
(Graduate School of Medicine, Juntendo University
Juntendo University School of Medicine
Atopy (Allergy) Research Center, Graduate School of Medicine, Juntendo University)
- David M. Thomas
(Garvan Institute of Medical Research)
- Mark J. Smyth
(Cancer Immunology Program, Peter MacCallum Cancer Centre, St Andrews Place
Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute
School of Medicine, University of Queensland)
Abstract
Genetic evolution that occurs during cancer progression enables tumour heterogeneity, thereby fostering tumour adaptation, therapeutic resistance and metastatic potential. Immune responses are known to select (immunoedit) tumour cells displaying immunoevasive properties. Here we address the role of IFN-γ in mediating the immunoediting process. We observe that, in several mouse tumour models such as HA-expressing 4T1 mammary carcinoma cells, OVA-expressing EG7 lymphoma cells and CMS5 MCA-induced fibrosarcoma cells naturally expressing mutated extracellular signal-regulated kinase (ERK) antigen, the action of antigen-specific cytotoxic T cell (CTL) in vivo results in the emergence of resistant cancer cell clones only in the presence of IFN-γ within the tumour microenvironment. Moreover, we show that exposure of tumours to IFN-γ-producing antigen-specific CTLs in vivo results in copy-number alterations (CNAs) associated with DNA damage response and modulation of DNA editing/repair gene expression. These results suggest that enhanced genetic instability might be one of the mechanisms by which CTLs and IFN-γ immunoedits tumours, altering their immune resistance as a result of genetic evolution.
Suggested Citation
Kazuyoshi Takeda & Masafumi Nakayama & Yoshihiro Hayakawa & Yuko Kojima & Hiroaki Ikeda & Naoko Imai & Kouetsu Ogasawara & Ko Okumura & David M. Thomas & Mark J. Smyth, 2017.
"IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting,"
Nature Communications, Nature, vol. 8(1), pages 1-13, April.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14607
DOI: 10.1038/ncomms14607
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14607. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.